# Biofourmis

> Biofourmis supplies connected monitoring technology, personalized analytics, and clinical and home-service coordination to hospitals, health systems, and payers. Founded in Singapore in 2015 and now based in Massachusetts, it merged with CopilotIQ in 2024. Its Biofourmis Connect clinical-trials division was acquired by ActiGraph in January 2025.

- **Founded:** 2015
- **Headquarters:** Needham, United States
- **Founders:** Kuldeep Singh Rajput (Co-founder and former CEO), Wendou Niu (Co-founder; historically Chief Privacy Officer)
- **Products:** Biovitals Analytics Engine, Biofourmis Care, Hospital at Home, Timely Discharge, SNF at Home
- **Notable:** FDA 510(k) clearance for Biovitals Analytics Engine in 2019., Series D reached US$320 million in 2022., Announced care-delivery relationships with major U.S. health systems.

## Products & services

- **Biovitals Analytics Engine** — Personalized physiological analytics for ambulatory monitoring; received FDA 510(k) clearance in 2019.
- **Biofourmis Care** — Care-at-home technology and configurable clinical services for enterprise healthcare organizations.
- **Hospital at Home** — Continuous and episodic monitoring plus coordinated services for selected acute patients at home.
- **Timely Discharge** — Supports completion of the final one or two inpatient days at home, with subsequent remote management.
- **SNF at Home** — Home-based skilled nursing and therapy support following discharge.
- **Remote Patient Management** — Care plans, patient engagement, and monitoring for post-discharge care.
- **Biofourmis Connect (divested)** — Digital clinical-trials platform acquired by ActiGraph in January 2025; a historical Biofourmis offering.

## Achievements

- FDA 510(k) clearance for Biovitals Analytics Engine in 2019.
- Series D reached US$320 million in 2022.
- Announced care-delivery relationships with major U.S. health systems.

## Latest updates

- **2026-02** — Singapore police announced financial-crime allegations concerning Biofourmis Holdings’ former CEO. The allegations concern historical invoices and representations; they are not findings of guilt.
- **2025-01** — ActiGraph announced acquisition of Biofourmis Connect on January 7; transaction price was not disclosed in the announcement.
- **2025-01** — AdventHealth collaboration announced January 6.
- **2024-11** — Lee Health remote-care expansion announced.
- **2024-10** — Strategic merger with CopilotIQ announced under CEO David Koretz.

## Links

- Website: https://biofourmis.com/
- LinkedIn: https://www.linkedin.com/company/biofourmis/
- Twitter/X: https://twitter.com/biofourmis
- YouTube: https://www.youtube.com/channel/UCx8lhNrxf1ICmLvdJBkzTIQ
- Facebook: https://facebook.com/biofourmis-singapore-pte-ltd-1164390220312645

---

Profile page: https://yespress.io/biofourmis
Published by YesPress — https://yespress.io
Last updated: 2026-10-25